Anne-Marie Mes-Mason

No ORCID on file · 2 papers in corpus
article 2015
·doi:10.1158/1557-3265.ovcasymp14-as18

Abstract Introduction: Clear Cell ovarian carcinomas (CCC) represent 10% of ovarian carcinomas, with outcomes for high-stage significantly worse than high-grade serous form. The complete mutational landscape, the molecular basis of the tran…

article 2014
·doi:10.1158/1538-7445.am2014-lb-312

Abstract Clear Cell ovarian carcinomas (CCC) represent ∼10% of ovarian carcinomas, with outcomes for high-stage cases significantly worse than the more common high-grade serous form. Response to standard chemotherapies are poor and efforts …